Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 3/20 | 0.51 |
| ▸ | MCHR1 | Q99705 | 5/20 | 0.48 |
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.46 |
| ▸ | MCHR2 | Q969V1 | 1/20 | 0.46 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.44 |
| ▸ | DRD2 | P14416 | 2/20 | 0.43 |
| ▸ | HRH2 | P25021 | 1/20 | 0.43 |
| ▸ | HRH1 | P35367 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6081977 | 0.83 | LTA4H (0.56) | LTA4HMCHR1HRH3KCNH2MCHR2 | |
| SCHEMBL6082223 | 0.82 | GRIN2D (0.52) | LTA4HMCHR1HRH3KCNH2MCHR2 | |
| SCHEMBL6083117 | 0.81 | DRD2 (0.59) | LTA4HMCHR1HRH3KCNH2MCHR2 | |
| SCHEMBL1728438 | 0.81 | LTA4H (0.56) | LTA4HMCHR1HRH3KCNH2MCHR2 | |
| SCHEMBL1728674 | 0.81 | ALDH1A1 (0.60) | LTA4HMCHR1HRH3KCNH2MCHR2 | |
| SCHEMBL6081563 | 0.81 | LTA4H (0.55) | LTA4HMCHR1HRH3KCNH2MCHR2 | |
| SCHEMBL1728604 | 0.80 | DRD3 (0.59) | LTA4HMCHR1KCNH2DRD2 | |
| SCHEMBL1728503 | 0.80 | LTA4H (0.54) | LTA4HMCHR1HRH3KCNH2MCHR2 | |
| SCHEMBL1729170 | 0.80 | LTA4H (0.51) | LTA4HMCHR1HRH3KCNH2MCHR2 | |
| SCHEMBL1728694 | 0.80 | KDM4E (0.56) | LTA4HMCHR1HRH3KCNH2MCHR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1551810-B1 | DIARYL-SUBSTITUTED CYCLIC UREA DERIVATIVES HAVING AN MCH-MODULATORY EFFECT | SANOFI AVENTIS DEUTSCHLAND (DE) | 2011-11-30 | — | — | EP | disclosed |
| US-7141561-B2 | Substituted diaryl heterocycles, process for their preparation and their use as medicaments | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2006-11-28 | — | — | US | disclosed |